Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases.
Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
Nitric oxide plays a dual role in the oxidative injury of cultured rat microglia but not astroglia.
Diffusion MRI abnormalities detection with orientation distribution functions: A multiple sclerosis longitudinal study.
A systematic review of drugs in late-stage development for the treatment of multiple sclerosis: a focus on oral synthetic drugs.
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
Cerebrospinal fluid proteomics: A new window for understanding human demyelinating disorders?
Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.
Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor.
Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein.
Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination.
Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP).
Caregiver burden in multiple sclerosis: A structured review of the instruments.
Upregulation of voltage-gated Ca(2+) channels in mouse astrocytes infected with Theiler's murine encephalomyelitis virus (TMEV).
Percutaneous angioplasty of internal jugular and azygous veins in patients with chronic cerebrospinal venous insufficiency and multiple sclerosis: early and mid-term results.
Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients.
Pharmacogenomics of interferon beta and glatiramer acetate response: A review of the literature.
Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.
The gateway theory: bridging neural and immune interactions in the CNS.
Autoimmunity in multiple sclerosis need not be abnormal.
A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: Is there a link between the two diseases?
Ion Channels in Neurological Disorders.
Month of birth and risk of multiple sclerosis: confounding and adjustments.
Spinal anesthesia for cesarean delivery in a woman with neuromyelitis optica.
CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo.
Pages
« first
‹ previous
…
600
601
602
603
604
605
606
607
608
…
next ›
last »